American Healthcare REIT (AHR) Proxy filing summary

Executive summary

• The annual meeting is scheduled for June 24, 2026, with voting on director elections, auditor ratification, and executive compensation approval.

• The company achieved the highest total shareholder return among healthcare REITs and all MSCI US REIT Index constituents since IPO, with an 80% TSR for 2025.

• As of December 31, 2025, the portfolio included $5.4 billion in healthcare real estate assets across 337 properties.

• The company raised $1.5 billion in equity offerings in 2025 and maintained a strong balance sheet with no outstanding floating rate debt.

Voting matters and shareholder proposals

• Stockholders will vote on electing nine directors for one-year terms, ratifying Deloitte & Touche LLP as auditor for 2026, and approving executive compensation on an advisory basis.

• The board recommends voting FOR all proposals.

• Stockholders of record as of April 1, 2026, are entitled to vote, with each share entitled to one vote.

Board of directors and corporate governance

• The board consists of nine directors, seven of whom are independent.

• Directors bring expertise in finance, real estate, healthcare, and governance.

• The board has Audit, Compensation, and Nominating and Corporate Governance Committees, all composed of independent directors.

• Annual board and committee evaluations are conducted, and stockholders can amend bylaws by majority vote.

• The company emphasizes diversity, with 33% board diversity in gender and ethnicity.